Abstract
The synthesis of two 1,2,4-benzothiadiazine derivatives, namely, 6-bromo-4H-spiro[1,2,4-benzothiadiazine- 3,1′-cyclobutane] 1,1-dioxide (1) and 6-bromo-1′-ethyl-4H-spiro[1,2,4-benzothiadiazine-3,4′- piperidine] 1,1-dioxide (2) is described in the present work. The synthesized compounds were studied by IR, 1H and 13C NMR, and single crystal X-ray diffraction to determine their molecular and crystal structure. In both structures the conformation of the 1,2,4-thiadiazinane ring is a twisted chair and is stabilized by the intramolecular interaction of the C–H…O type. Compound 1 crystallizes in the monoclinic crystal system and space group C2/c with the unit cell parameters a = 15.8690(17) Å, b = 12.1453(16) Å, c = 12.0152(15) Å, β = 99.686(7)°, Z = 8 and V = 2282.7(5) Å3. Compound 2 crystallizes in the monoclinic crystal system and space group P21/c with the unit cell parameters a = 14.5748(6) Å, b = 9.3340(5) Å, c = 12.4283(6) Å, β = 112.757(2)°, Z = 4 and V = 1559.14(13) Å3. In the crystal structures different packing motifs are implemented with the formation of supramolecular assemblies of different types due to classical hydrogen bonds such as N–H…O and intermolecular interactions of N–H…Br, N–H…N, C–H…O types and π…π stacking.
Similar content being viewed by others
References
J. I. Truhillo, J. R. Kiefer, W. Huang, et al., Bioorg. Med. Chem. Lett., 19, 908–911 (2009).
C.-H. Lee, M. Jiang, M. Cowart, et al., J. Med. Chem., 44, 2133–2138 (2001).
A. Cordi, M. Spedding, B. Serkiz, et al., Chem. Abstr. (US Patent), 124, 261085 (1996).
R. T. Sarisky, J. Antimicrob. Chemother., 54, 14 (2004).
M. Di Bella, A. Monzani, M. G. Andrisano, et al., Farmaco, Ed. Sci., 38, 466 (1983).
A. Kamal, K. S. Reddy, S. K. Ahmed, et al., Bioorg. Med. Chem., 14, 650 (2006).
F. Impagnatiello, A. Oberto, P. Longone, et al., Proc. Natl. Acad. Sci. USA, 94, 7053 (1997).
J. K. Wales, S. V. Krees, A. M. Grant, et al., J. Pharmacol. Exp. Ther., 164, 421–432 (1968).
A. Scozzofava, T. Owa, A. Mastrolorenzo, et al., Curr. Med. Chem., 10, 925–953 (2003).
A. Casini, A. Scozzafava, A. Mastrolorenco, et al., Curr. Cancer Drug Targets, 2, 55–75 (2002).
A. Scozzafava, A. Casini, and C. T. Supuran, Curr. Med. Chem., 9, 1167–1185 (2002).
E. M. Arranz, J. A. Díaz, S. T. Ingate, et al., Bioorg. Med. Chem., 7, 2811–2822 (1999).
Y. Wang, J. Busch-Petersen, F. Wang, et al., Bioorg. Med. Chem. Lett., 17, 3864–3867 (2007).
S. Hayao, W. Stryker, B. Phillips, et al., J. Med. Chem., 11, 1246–1248 (1968).
S. Khelili, N. Kihal, M. Yekhlef, et al., J. Med. Chem., 54, 873–878 (2012).
P. de Tullio, A.-C. Servais, M. Fillet, et al., J. Med. Chem., 54, 8353–8361 (2011).
P. Francotte, E. Goffin, P. Fraikin, et al., J. Med. Chem., 53, 1700–1711 (2010).
B. Pirotte, P. de Tullio, Q.-A. Nguyen, et al., J. Med. Chem., 53, 147–154 (2010).
P. Francotte, P. de Tullio, E. Goffin, et al., J. Med. Chem., 50, 3153–3157 (2007).
K. D. Combrink, H. B. Gulgeze, J. W. Thuring, et al., Bioorg. Med. Chem. Lett., 17, 4784–4790 (2007).
S. Boverie, M.-H. Antoine, F. Somers, et al., J. Med. Chem., 48, 3492–3503 (2005).
Y. Girard, J. G. Atkinson, and J. Rokach, J. Chem. Soc., Perkin Trans., 1043–1047 (1979).
J.-W. Chern, C.-P. Ho, Y.-H. Wu, et al., J. Heterocycl. Chem., 27, 1909–1915 (1990).
A. Cherepakha, V. O. Kovtunenko, A. Tolmachev, and O. Lukin, Tetrahedron, 67, 6233–6239 (2011).
S. Hirota, T. Sakai, N. Kitamura, et al., Tetrahedron, 66, 653–662 (2010).
D. Yang, H. Liu, H. Yang, et al., Adv. Synth. Catal., 351, 1999–2004 (2009).
A. Rolfe and P. R. Hanson, Tetrahedron Lett., 50, 6935–6937 (2009).
S. Hirota, R. Kato, M. Suzuki, et al., Eur. J. Org. Chem., 2075–2083 (2008).
C. Blackburn, A. Achab, A. Elder, et al., J. Org. Chem., 70, 10206–10209 (2005).
W. Su, H. Cai, and B. Yang, J. Chem. Res., 87/88 (2004).
S. Makino, E. Nakanishi, and T. Tsuji, J. Comb. Chem., 5, 73–78 (2003).
Bruker, APEX2, SADABS and SAINT-Plus, Bruker AXS Inc., Madison, Wisconsin, USA (2009).
G. M. Sheldrick, Acta Crystallogr., A64, 112–122 (2008).
L. J. Farrugia, J. Appl. Crystallogr., 30, 565/566 (1997).
C. F. Macrae, I. J. Bruno, J. A. Chisholm, et al., J. Appl. Crystallogr., 41, 466–470 (2008).
J. Bernstein, R. E. Davis, L. Shimoni, and N. L. Chang, Angew. Chem., Int. Ed. Engl., 34, 1555–1573 (1995).
D. Cremer and J. A. Pople, J. Am. Chem. Soc., 97, No. 6, 1354–1358 (1975).
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © 2015 P. P. S. Kumar, P. A. Suchetan, S. Sreenivasa, S. Naveen, N. K. Lokanath, D. B. A. Kumar.
The text was submitted by the authors in English. Zhurnal Strukturnoi Khimii, Vol. 56, No. 7, pp. 1449-1456, November-December, 2015.
Rights and permissions
About this article
Cite this article
Kumar, P.P.S., Suchetan, P.A., Sreenivasa, S. et al. Molecular and crystal structures of two 1,2,4-benzothiadiazine derivatives. J Struct Chem 56, 1390–1397 (2015). https://doi.org/10.1134/S0022476615070215
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0022476615070215